| A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects (NCT05108038) | Chong Kun Dang Pharmaceutical | 2021-10-07 |
| Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy Participants (NCT05050682) | Pfizer | 2021-10-07 |
| A Phase I/II Open Label Single Centre Trial to Assess the Safety, Tolerability and Efficacy of Single Dose Neoadjuvant Anti-CLEVER-1 Antibody Bexmarilimab in Localised Renal Cell and Colon Carcinoma (NCT05104905) | Faron Pharmaceuticals Ltd | 2021-10-07 |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors (NCT05067972) | Pfizer | 2021-10-07 |
| Stem Cell Therapy for Chronic Kidney Disease (NCT04869761) | LaTonya J. Hickson | 2021-10-07 |
| Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis (NCT03211793) | UMC Utrecht | 2021-10-06 |
| Study of LM-102 in Patients With Advance Solid Tumors (NCT05008445) | LaNova Medicines Development Co., Ltd. | 2021-10-06 |
| A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance (NCT05102370) | Memorial Sloan Kettering Cancer Center | 2021-10-06 |
| Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma (NCT04688658) | John Kirkwood | 2021-10-06 |
| Brain Insulin Resistance in Mood Disorders (NCT03915613) | University Health Network, Toronto | 2021-10-06 |
| Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions (NCT05061901) | Pharmtechnology LLC | 2021-10-06 |
| A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants (NCT05073003) | GlaxoSmithKline | 2021-10-06 |
| Study to Evaluate the Safety and Tolerability of ABL501, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL501 in Subjects With Any Progressive, Locally Advanced (Unresectable) or Metastatic Solid Tumors (NCT05101109) | ABL Bio, Inc. | 2021-10-06 |
| Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects (NCT06037395) | Celltrion | 2021-10-06 |
| Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes. (NCT03807973) | University of Alabama at Birmingham | 2021-10-05 |
| A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants (NCT05069896) | Eli Lilly and Company | 2021-10-05 |
| Behavior Change Techniques (BCTs) to Improve Low Intensity Physical Activity in Older Adults (NCT04967313) | Northwell Health | 2021-10-05 |
| Therapeutic Response of Cannabidiol in Rheumatoid Arthritis (NCT04911127) | University of California, Los Angeles | 2021-10-05 |
| A Phase 1 Clinical Trial to Explore Systemic Exposure of CTO0101 Eye Drops, Safety and Local Tolerability in Healthy Adults (NCT05262179) | Taejoon Pharmaceutical Co., Ltd. | 2021-10-05 |
| Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma (NCT04975399) | Celgene | 2021-10-05 |
| Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects (NCT05023031) | NVP Healthcare | 2021-10-05 |
| TriPRIL CAR T Cells in Multiple Myeloma (NCT05020444) | Marcela V. Maus, M.D.,Ph.D. | 2021-10-05 |
| Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1) (NCT05060107) | Francisco Espinoza | 2021-10-05 |
| Study to Assess the Effect of AZD4831 on the Pharmacokinetics (Drug Behavior in the Body) of Midazolam (NCT05052710) | AstraZeneca | 2021-10-05 |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers (NCT04708470) | National Cancer Institute (NCI) | 2021-10-05 |
| Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors (NCT05002868) | Rhizen Pharmaceuticals SA | 2021-10-05 |
| Study of INCA 0186 in Subjects With Advanced Solid Tumors (NCT04989387) | Incyte Corporation | 2021-10-04 |
| Extubation Advisor: Initial Implementation and Evaluation of a Novel Extubation Clinical Decision Support Tool (NCT04708509) | Ottawa Hospital Research Institute | 2021-10-04 |
| Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants (NCT05062785) | Robert Silbergleit | 2021-10-04 |
| Study to Evaluate the Safety of SP-104 (NCT04958876) | Scilex Pharmaceuticals, Inc. | 2021-10-04 |
| A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (NCT04853017) | Elicio Therapeutics | 2021-10-04 |
| Fluorescent Imaging of Nerves With Illuminare-1 During Surgery (NCT04983862) | Memorial Sloan Kettering Cancer Center | 2021-10-04 |
| Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates (NCT05064488) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2021-10-04 |
| Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease (NCT05022147) | James Liao | 2021-10-04 |
| A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors (NCT05025085) | Agenus Inc. | 2021-10-04 |
| Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19） (NCT05065619) | Medicago | 2021-10-02 |
| Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell Carcinoma (NCT04969354) | The Affiliated Hospital of Xuzhou Medical University | 2021-10-01 |
| Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects (NCT04309734) | Atea Pharmaceuticals, Inc. | 2021-10-01 |
| Housing Transitions QUERI (NCT05312229) | VA Office of Research and Development | 2021-10-01 |
| Assessment Crestal Maxillary Sinus Membrane Elevation Using Different Implant Heights (NCT05166434) | Cairo University | 2021-10-01 |
| Nitric Oxide During CPB to Reduce AKI in Neonates (NCT03946462) | Fabio Savorgnan | 2021-10-01 |
| First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers (NCT04994912) | Elixiron Immunotherapeutics (Hong Kong) Ltd. | 2021-10-01 |
| A Study of CST-2032 in Subjects With Cognitive Impairment (NCT05033912) | CuraSen Therapeutics, Inc. | 2021-10-01 |
| A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL (NCT05054465) | Israeli Medical Association | 2021-10-01 |
| Multiple-Ascending Dose in Japanese Patients Bridging Study (NCT05065359) | Altavant Sciences GmbH | 2021-10-01 |
| Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma (NCT05047276) | José María Piulats Rodríguez | 2021-10-01 |
| Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver Metastasis (NCT05070221) | Peking University Cancer Hospital & Institute | 2021-10-01 |
| A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors (NCT05036291) | Ningbo Newbay Technology Development Co., Ltd | 2021-10-01 |
| A Study of HS269 in Patients With Advanced Solid Tumors (NCT05058352) | Zhejiang Hisun Pharmaceutical Co. Ltd. | 2021-10-01 |
| A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer (NCT05079698) | Memorial Sloan Kettering Cancer Center | 2021-10-01 |
| Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections (NCT04722029) | Nationwide Children's Hospital | 2021-10-01 |
| Phase Ib Study of FURMONERTINIB in Patients with NSCLC Having Exon 20 Insertion Mutation (NCT04958967) | Allist Pharmaceuticals, Inc. | 2021-10-01 |
| Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]Adavosertib (NCT05008913) | AstraZeneca | 2021-10-01 |
| Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer (NCT04592211) | Yonsei University | 2021-10-01 |
| Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects (NCT05149274) | Daewoong Pharmaceutical Co. LTD. | 2021-10-01 |
| A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection (NCT05047445) | Scancell Ltd | 2021-10-01 |
| Microtransplantation for Ovarian Cancer (NCT05095558) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2021-10-01 |
| Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC (NCT05021328) | Hubei Cancer Hospital | 2021-10-01 |
| ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas (NCT05079022) | Peking University People's Hospital | 2021-10-01 |
| AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects. (NCT05170737) | Aelis Farma | 2021-10-01 |
| A Study of SKLB1028 in Patients With Advanced Solid Tumor (NCT05072522) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-10-01 |
| Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients (NCT05080543) | Amany Mousa Salama Muhammed | 2021-10-01 |
| Single and Multiple Doses of HA115 and Food Effect in Healthy Adult Volunteers (NCT03567694) | Conjupro Biotherapeutics, Inc. | 2021-10-01 |
| TTI-0102 for Veterans With TBI (NCT04262895) | VA Office of Research and Development | 2021-10-01 |
| Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease (NCT05305833) | TC Erciyes University | 2021-10-01 |
| Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers (NCT05085587) | Respirent Pharmaceuticals Co Ltd. | 2021-10-01 |
| Influence of Morphine or Ketamine or Saline Applied During In-hospital Cardiopulmonary Resuscitation on Early Survival (NCT04009759) | University Hospital, Akershus | 2021-10-01 |
| Anti-mesothelin CAR-T Cells With Advanced Refractory Solid Tumors (NCT04981691) | Ruijin Hospital | 2021-10-01 |
| Preliminary Safety and Efficacy of XT-150 in Facet Joint Osteoarthritis (NCT04841512) | Xalud Therapeutics, Inc. | 2021-10-01 |
| Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations (NCT05222165) | Helsinn Healthcare SA | 2021-10-01 |
| Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer (NCT05019690) | Fujian Cancer Hospital | 2021-10-01 |
| A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients (NCT05281926) | National Taiwan University Hospital | 2021-10-01 |
| Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis (NCT05068453) | Peking University Cancer Hospital & Institute | 2021-10-01 |
| A Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries (NCT04893863) | University of Manitoba | 2021-10-01 |
| Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets (NCT04199624) | Indiana University | 2021-10-01 |
| Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS (NCT05029609) | Tiziana Life Sciences LTD | 2021-10-01 |
| Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE) (NCT05457491) | Mayo Clinic | 2021-10-01 |
| Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets (NCT06431438) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-10-01 |
| IMC001 for Clinical Research on Advanced Digestive System Malignancies (NCT05028933) | Zhejiang University | 2021-09-30 |
| Study of Oral LOXO-338 in Patients With Advanced Blood Cancers (NCT05024045) | Eli Lilly and Company | 2021-09-30 |
| AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer (NCT04973683) | M.D. Anderson Cancer Center | 2021-09-30 |
| 177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma (NCT04167618) | Y-mAbs Therapeutics | 2021-09-30 |
| A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease (NCT05328115) | Alzinova AB | 2021-09-30 |
| IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors (NCT05039801) | M.D. Anderson Cancer Center | 2021-09-30 |
| KZR-261 in Subjects With Advanced Solid Malignancies (NCT05047536) | Kezar Life Sciences, Inc. | 2021-09-30 |
| Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy (NCT04985760) | Madhu Chhanda Choudhary | 2021-09-30 |
| Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19 (NCT04964414) | Amanda Stapleton | 2021-09-30 |
| ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD) (NCT05006885) | Altimmune, Inc. | 2021-09-30 |
| Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer (NCT05435274) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-09-30 |
| Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment (NCT06266572) | Center for Social Innovation, Massachusetts | 2021-09-30 |
| A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults (NCT05061563) | Bayer | 2021-09-30 |
| First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors (NCT05054348) | Immune-Onc Therapeutics | 2021-09-30 |
| Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF. (NCT04866056) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2021-09-30 |
| Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors (NCT03068832) | Washington University School of Medicine | 2021-09-30 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SR1375 (NCT05026008) | Shanghai SIMR Biotechnology Co., Ltd. | 2021-09-30 |
| A Study of NX-1607 in Adults With Advanced Malignancies (NCT05107674) | Nurix Therapeutics, Inc. | 2021-09-29 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856 (NCT05077501) | AlzeCure Pharma | 2021-09-29 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers (NCT04216342) | National Heart, Lung, and Blood Institute (NHLBI) | 2021-09-29 |
| Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma (NCT04941274) | National Cancer Institute (NCI) | 2021-09-29 |
| TEIPP Immunotherapy in Patients With NSCLC (NCT05898763) | Erasmus Medical Center | 2021-09-29 |